4XXC
HLA-B*1801 in complex with a self-peptide, DELEIKAY
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX1 |
Synchrotron site | Australian Synchrotron |
Beamline | MX1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-10-01 |
Detector | ADSC QUANTUM 210 |
Wavelength(s) | 0.987 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 50.660, 80.800, 108.980 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 24.170 - 1.426 |
R-factor | 0.2056 |
Rwork | 0.204 |
R-free | 0.23490 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4jqv |
RMSD bond length | 0.006 |
RMSD bond angle | 1.071 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX ((phenix.refine: 1.8.1_1168)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 24.670 | 1.500 |
High resolution limit [Å] | 1.426 | 1.430 |
Rmerge | 0.047 | 0.283 |
Number of reflections | 80489 | |
<I/σ(I)> | 7.7 | 2.2 |
Completeness [%] | 95.8 | 91.7 |
Redundancy | 6.1 | 5.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | EVAPORATION | 5.6 | 273 | 14-20% PEG 4K, 0.2 M NH4Ac |